Your browser doesn't support javascript.
loading
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases.
Attauabi, Mohamed; Höglund, Camilla; Fassov, Janne; Pedersen, Kenneth Bo; Hansen, Heidi Bansholm; Wildt, Signe; Jensen, Michael Dam; Neumann, Anders; Lind, Cecilie; Jacobsen, Henrik Albaek; Popa, Ana-Maria; Kjeldsen, Jens; Pedersen, Natalia; Molazahi, Akbar; Haderslev, Kent; Aalykke, Claus; Knudsen, Torben; Cebula, Wojciech; Munkholm, Pia; Bendtsen, Flemming; Seidelin, Jakob Benedict; Burisch, Johan.
Afiliación
  • Attauabi M; Gastrounit, Medical Division, Copenhagen University Hospital, Hvidovre, Denmark.
  • Höglund C; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Hvidovre, Denmark.
  • Fassov J; Department of Gastroenterology and Hepatology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
  • Pedersen KB; Department of Medicine, Section of Gastroenterology, OUH Svendborg Hospital, Odense, Denmark.
  • Hansen HB; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Wildt S; Department of Medical Gastroenterology, Hospital of South West Denmark, Esbjerg, Denmark.
  • Jensen MD; Department of Gastroenterology, North Zealand University Hospital, Frederikssund, Denmark.
  • Neumann A; Department of Medicine, Division of Gastroenterology, Zealand University Hospital, Koege, Denmark.
  • Lind C; Department of Internal Medicine, Section of Gastroenterology, Lillebaelt Hospital, Vejle, Denmark.
  • Jacobsen HA; Department of Internal Medicine, Regional Hospital Viborg, Viborg, Denmark.
  • Popa AM; Department of Internal Medicine, Regional Hospital Viborg, Viborg, Denmark.
  • Kjeldsen J; Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Pedersen N; Department of Medicine, Nykoebing Falster Hospital, Nykoebing Falster, Denmark.
  • Molazahi A; Department of Medical Gastroenterology, OUH Odense University Hospital, Odense, Denmark.
  • Haderslev K; Department of Gastroenterology, Slagelse Hospital, Slagelse, Denmark.
  • Aalykke C; Department of Internal Medicine, Holbaek Hospital, Holbaek, Denmark.
  • Knudsen T; Department of Gastroenterology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Cebula W; Department of Medicine, Section of Gastroenterology, OUH Svendborg Hospital, Odense, Denmark.
  • Munkholm P; Department of Medical Gastroenterology, Hospital of South West Denmark, Esbjerg, Denmark.
  • Bendtsen F; Department of Medicine, Nykoebing Falster Hospital, Nykoebing Falster, Denmark.
  • Seidelin JB; Department of Gastroenterology, North Zealand University Hospital, Frederikssund, Denmark.
  • Burisch J; Gastrounit, Medical Division, Copenhagen University Hospital, Hvidovre, Denmark.
Scand J Gastroenterol ; 56(9): 1040-1048, 2021 09.
Article en En | MEDLINE | ID: mdl-34224299

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Anticuerpos Monoclonales Humanizados / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Scand J Gastroenterol Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Anticuerpos Monoclonales Humanizados / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Scand J Gastroenterol Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca